Evigrade
Moderate

Acetylsalicylic acid × diltiazem

Antiplatelet agents (low dose) / NSAIDs (analgesic dose)×Calcium channel blocker, non-DHP (benzothiazepine derivative)

Mechanism

Diltiazem impairs platelet function via calcium channel blockade; aspirin is an antiplatelet. Mild additive bleeding risk, rarely clinically significant.

Symptoms

Usually asymptomatic. In patients with bleeding risk factors (peptic ulcer, older age): rare gum bleeding and epistaxis.

Management

Standard combination in ischaemic heart disease. Cardioprotective aspirin doses (75–100 mg) are acceptable without special measures. In patients with bleeding risk factors: PPI cover with pantoprazole.

Check the full regimen, not just this pair

Opens the checker with these two drugs prefilled. Add the rest of the regimen and recompute additive risks.

Open checker

Sources

All interactions